跳至主要内容
临床试验/KCT0000985
KCT0000985已完成未知

An open-label, randomized, single-dose crossover study to compare the pharmacokinetics after the administration of HCP1201 tablet 500/10 mg and coadministration of metformin SR 500 mg and rosuvastatin 10 mg in healthy volunteers

Hanmi Pharm0 个研究点目标入组 72 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
72

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
20(Year) 至 55(Year)(—)
性别
Male

入选标准

  • 1) Healthy male volunteer, age 20~55 years
  • 2) The result of Body Mass Index(BMI) is not less than 19 kg/m2 , no more than 27 kg/m2
  • 3) Subject who has the ability to comprehend the study objectives, contents and the property of the study drug before participating in the trial
  • 4) Subject who has the ability and willingness to participate the whole period of trial

排除标准

  • 1) Presence of medical history or a concurrent disease that may interfere with treatment and safety assessment or completion of this clinical study, including clinically significant disorders in kidney, liver, cardiovascular system, respiratory system, endocrine system, or neuropsychiatric system.
  • 2) Glomerular filtration rate is under 60ml/min which is calculated by serum creatinine value.
  • 3) Liver enzyme (AST, ALT) level exceeds the maximum normal range more than one and a half times.
  • 4) SBP: lower than 90mmHg or higher than 150mmHg, DBP: lower thatn 60mmHg or higher than 100mmHg
  • 5) History of relevant drug allergies or clinically significant hypersensitivity reaction.
  • 6) Subjects who judged ineligible by the investigator.

研究者

发起方
Hanmi Pharm

相似试验